Unfavorable prognostic factors in patients with atrial fibrillation after successful transcatheter aortic valve implantation

Staroverova A.I.; Kropacheva E.S.; Panchenko E.P.; Komlev A.E.; Imaev T.E.

doi:https://doi.org/10.17116/Cardiobulletin20221704146

Close metadata

OBJECTIVE

To assess all-cause mortality and identify unfavorable clinical prognostic factors.

MATERIAL AND METHODS

We analyzed 130 patients (61 men, median age 79 years) with atrial fibrillation who underwent transcatheter aortic valve implantation at the National Medical Research Center of Cardiology between 2020 and 2022. Most patients had high risk of thromboembolic complications (median CHA₂DS₂-VASc score 5).

RESULTS

Mortality within 1.5 years after successful transcatheter aortic valve implantation was 8.4/100 patient-years. Cardiovascular mortality prevailed (73.3%). Predictors of all-cause mortality were senile asthenia and chronic kidney disease stage ≥3. In patients with atrial fibrillation who survived transcatheter aortic valve implantation, the predictor of all adverse events throughout 1.5-year follow-up was cancer.

Keywords:

atrial fibrillation

anticoagulation

transcatheter aortic valve implantation

fragility

frailty

chronic kidney disease

poor prognosis

all-cause mortality

Authors:

Staroverova A.I.

Chazov National Medical Research Center of Cardiology

Kropacheva E.S.

National Medical Research Center of Cardiology

Panchenko E.P.

National Medical Research Center of Cardiology

Komlev A.E.

Chazov National Research Center of Cardiology

ORCID: 0000-0001-6908-7472

Imaev T.E.

Chazov National Research Center of Cardiology

ORCID: 0000-0002-5736-5698

Received:

04.09.2022

Accepted:

09.09.2022

Close metadata

References:

Osnabrugge RL, Mylotte D, Head SJ, Van Mieghem NM, Nkomo VT, LeReun CM, Bogers AJ, Piazza N, Kappetein AP. Aortic stenosis in the elderly: disease prevalence and number of candidates for transcatheter aortic valve replacement: a meta-analysis and modeling study. JACC: Journal of the American College of Cardiology. 2013;62(11):1002-1012. https://doi.org/10.1016/j.jacc.2013.05.015
Zahn R, Gerckens U, Linke A, Sievert H, Kahlert P, Hambrecht R, Sack S, Abdel-Wahab M, Hoffmann E, Schiele R, Schneider S, Senges J. German Transcatheter Aortic Valve Interventions-Registry Investigators. Predictors of one-year mortality after transcatheter aortic valve implantation for severe symptomatic aortic stenosis. American Journal of Cardiology. 2013;112(2):272-279. https://doi.org/10.1016/j.amjcard.2013.03.024
Abdel-Wahab M, Zahn R, Gerckens U, Linke A, Sievert H, Schäfer U, Kahlert P, Hambrecht R, Sack S, Hoffmann E, Senges J, Schneider S, Richardt G. German TAVI Registry Investigators. Predictors of 1-year mortality in patients with aortic regurgitation after transcatheter aortic valve implantation: an analysis from the multicentre German TAVI registry. Heart. 2014;100(16):1250-1256. https://doi.org/10.1136/heartjnl-2013-305385
Quintana RA, Monlezun DJ, DaSilva-DeAbreu A, Sandhu UG, Okwan-Duodu D, Ramírez J, Denktas AE, Jneid H, Paniagua D. One-Year Mortality in Patients Undergoing Transcatheter Aortic Valve Replacement for Stenotic Bicuspid versus Tricuspid Aortic Valves: A Meta-Analysis and Meta-Regression. Journal of Interventional Cardiology. 2019;2019:8947204. https://doi.org/10.1155/2019/8947204
Shoeb M, Fang MC. Assessing bleeding risk in patients taking anticoagulants. Journal of Thrombosis and Thrombolysis. 2013;35(3):312-319. https://doi.org/10.1007/s11239-013-0899-7
Maan A, Heist EK, Passeri J, Inglessis I, Baker J, Ptaszek L, Vlahakes G, Ruskin JN, Palacios I, Sundt T, Mansour M. Impact of atrial fibrillation on outcomes in patients who underwent transcatheter aortic valve replacement. American Journal of Cardiology. 2015;115(2):220-226. https://doi.org/10.1016/j.amjcard.2014.10.027
Stortecky S, Buellesfeld L, Wenaweser P, Heg D, Pilgrim T, Khattab AA, Gloekler S, Huber C, Nietlispach F, Meier B, Jüni P, Windecker S. Atrial fibrillation and aortic stenosis: impact on clinical outcomes among patients undergoing transcatheter aortic valve implantation. Circulation: Cardiovascular Interventions. 2013;6(1):77-84. https://doi.org/10.1161/CIRCINTERVENTIONS.112.000124
Tarantini G, Mojoli M, Windecker S, Wendler O, Lefèvre T, Saia F, Walther T, Rubino P, Bartorelli AL, Napodano M, D’Onofrio A, Gerosa G, Iliceto S, Vahanian A. Prevalence and Impact of Atrial Fibrillation in Patients With Severe Aortic Stenosis Undergoing Transcatheter Aortic Valve Replacement: An Analysis From the SOURCE XT Prospective Multicenter Registry. JACC: Cardiovascular Interventions. 2016;9(9):937-946. https://doi.org/10.1016/j.jcin.2016.01.037
U.S. National Library of Medicine. ClinicalTrials.gov. Identifier: NCT01368250. https://clinicaltrials.gov/ct2/show/NCT01368250
U.S. National Library of Medicine. ClinicalTrials.gov. Identifier: NCT03192774. https://www.clinicaltrials.gov/ct2/show/NCT0319
Okuno T, Heg D, Lanz J, Praz F, Brugger N, Stortecky S, Windecker S, Pilgrim T. Refined staging classification of cardiac damage associated with aortic stenosis and outcomes after transcatheter aortic valve implantation. European Heart Journal — Quality of Care and Clinical Outcomes. 2021;7(6):532-541. https://doi.org/10.1093/ehjqcco/qcab041
Barili F, Freemantle N, Casado AP, Rinaldi M, Folliguet T, Musumeci F, Gerosa G, Parolari A. Corrigendum to «Mortality in trials on transcatheter aortic valve implantation versus surgical aortic valve replacement: a pooled meta-analysis of Kaplan-Meier-derived individual patient data». Eur J Cardiothorac Surg. 2020;58:221-229. European Journal of Cardio-Thoracic Surgery. 2020;58(2):409. https://doi.org/10.1093/ejcts/ezaa157
Arangalage D, Cimadevilla C, Alkhoder S, Chiampan A, Himbert D, Brochet E, Iung B, Nataf P, Depoix JP, Vahanian A, Messika-Zeitoun D. Agreement between the new EuroSCORE II, the Logistic EuroSCORE and the Society of Thoracic Surgeons score: implications for transcatheter aortic valve implantation. Archives of Cardiovascular Diseases. 2014;107(6-7):353-360. https://doi.org/10.1016/j.acvd.2014.05.002
Watanabe Y, Hayashida K, Lefèvre T, Chevalier B, Hovasse T, Romano M, Garot P, Farge A, Donzeau-Gouge P, Bouvier E, Cormier B, Morice MC. Is EuroSCORE II better than EuroSCORE in predicting mortality after transcatheter aortic valve implantation? Catheterization and Cardiovascular Interventions. 2013;81(6):1053-1060. https://doi.org/10.1002/ccd.24702
Durand E, Borz B, Godin M, Tron C, Litzler PY, Bessou JP, Dacher JN, Bauer F, Cribier A, Eltchaninoff H. Performance analysis of EuroSCORE II compared to the original logistic EuroSCORE and STS scores for predicting 30-day mortality after transcatheter aortic valve replacement. American Journal of Cardiology. 2013;111(6):891-897. https://doi.org/10.1016/j.amjcard.2012.11.056
Goudzwaard JA, de Ronde-Tillmans MJAG, van Hoorn FED, Kwekkeboom EHC, Lenzen MJ, van Wiechen MPH, Ooms JFW, Nuis RJ, Van Mieghem NM, Daemen J, de Jaegere PPT, Mattace-Raso FUS. Impact of frailty on health-related quality of life 1 year after transcatheter aortic valve implantation. Age Ageing. 2020;49(6):989-994. https://doi.org/10.1093/ageing/afaa071
Afilalo J, Alexander KP, Mack MJ, Maurer MS, Green P, Allen LA, Popma JJ, Ferrucci L, Forman DE. Frailty assessment in the cardiovascular care of older adults. JACC: Journal of the American College of Cardiology. 2014;63(8):747-762. https://doi.org/10.1016/j.jacc.2013.09.070
Green P, Russo M, Arnold S, Doshi D, Pichard AD, Szeto WY, Makkar RR, Babaliaros VC, Fearon WF, Svensson LG, Webb JG, Nazif, Zajarias A, Quader N, Parvataneni R, Kirtane AJ, Cohen DJ, Mack MJ, Leon MB. TCT-36 Frailty in Intermediate Risk Patients Undergoing Transcatheter or Surgical Aortic Valve Replacement, Cut Points and Relationship With Outcomes: An Analysis of the Placement of Aortic Transcatheter Valves (PARTNER) 2 Cohort A Randomized Trial. Journal of the American College of Cardiology. 2016;68(18S):B15. https://doi.org/10.1016/j.jacc.2016.09.058
Sannino A, Gargiulo G, Schiattarella GG, Perrino C, Stabile E, Losi MA, Galderisi M, Izzo R, de Simone G, Trimarco B, Esposito G. A meta-analysis of the impact of pre-existing and new-onset atrial fibrillation on clinical outcomes in patients undergoing transcatheter aortic valve implantation. EuroIntervention. 2016;12(8):1047-1056. https://doi.org/10.4244/EIJY15M11_12
Mojoli M, Gersh BJ, Barioli A, Masiero G, Tellaroli P, D’Amico G, Tarantini G. Impact of atrial fibrillation on outcomes of patients treated by transcatheter aortic valve implantation: A systematic review and meta-analysis. American Heart Journal. 2017;192:64-75. https://doi.org/10.1016/j.ahj.2017.07.005
Sannino A, Stoler RC, Lima B, Szerlip M, Henry AC, Vallabhan R, Kowal RC, Brown DL, Mack MJ, Grayburn PA. Frequency of and Prognostic Significance of Atrial Fibrillation in Patients Undergoing Transcatheter Aortic Valve Implantation. American Journal of Cardiology. 2016;118(10):1527-1532. https://doi.org/10.1016/j.amjcard.2016.08.017
Gargiulo G, Capodanno D, Sannino A, Perrino C, Capranzano P, Stabile E, Trimarco B, Tamburino C, Esposito G. Moderate and severe preoperative chronic kidney disease worsen clinical outcomes after transcatheter aortic valve implantation: meta-analysis of 4992 patients. Circulation: Cardiovascular Interventions. 2015;8(2):e002220. https://doi.org/10.1161/CIRCINTERVENTIONS.114.002220
Rattanawong P, Kanitsoraphan C, Kewcharoen J, Riangwiwat T, Chongyangyuenvong P, Vutthikraivit W, Mannem SR, Chung EH. Chronic kidney disease is associated with increased mortality and procedural complications in transcatheter aortic valve replacement: a systematic review and meta-analysis. Catheterization and Cardiovascular Interventions. 2019;94(3):116-127. https://doi.org/10.1002/ccd.28102
Dumonteil N, van der Boon RM, Tchetche D, Chieffo A, Van Mieghem NM, Marcheix B, Buchanan GL, Vahdat O, Serruys PW, Fajadet J, Colombo A, de Jaegere PP, Carrié D. Impact of preoperative chronic kidney disease on short- and long-term outcomes after transcatheter aortic valve implantation: a Pooled-RotterdAm-Milano-Toulouse In Collaboration Plus (PRAGMATIC-Plus) initiative substudy. American Heart Journal. 2013;165(5):752-760. https://doi.org/10.1016/j.ahj.2012.12.013
Allende R, Webb JG, Munoz-Garcia AJ, de Jaegere P, Tamburino C, Dager AE, Cheema A, Serra V, Amat-Santos I, Velianou JL, Barbanti M, Dvir D, Alonso-Briales JH, Nuis RJ, Faqiri E, Imme S, Benitez LM, Cucalon AM, Al Lawati H, Garcia del Blanco B, Lopez J, Natarajan MK, DeLarochellière R, Urena M, Ribeiro HB, Dumont E, Nombela-Franco L, Rodés-Cabau J. Advanced chronic kidney disease in patients undergoing transcatheter aortic valve implantation: insights on clinical outcomes and prognostic markers from a large cohort of patients. European Heart Journal. 2014;35(38):2685-2696. https://doi.org/10.1093/eurheartj/ehu175
Yamamoto M, Hayashida K, Mouillet G, Hovasse T, Chevalier B, Oguri A, Watanabe Y, Dubois-Randé JL, Morice MC, Lefèvre T, Teiger E. Prognostic value of chronic kidney disease after transcatheter aortic valve implantation. JACC: Journal of the American College of Cardiology. 2013;62(10):869-877. https://doi.org/10.1016/j.jacc.2013.04.057
Wang J, Liu S, Han X, Chen Y, Chen H, Dong S, Song B. Impact of Chronic Kidney Disease on the Prognosis of Transcatheter Aortic Valve Replacement in Patients with Aortic Stenosis: A Meta-Analysis of 133624 Patients. Annals of Thoracic and Cardiovascular Surgery. 2022;28(2):83-95. https://doi.org/10.5761/atcs.ra.21-00187
Thompson MQ, Theou O, Tucker GR, Adams RJ, Visvanathan R. FRAIL scale: Predictive validity and diagnostic test accuracy. Australasian Journal on Ageing. 2020;39(4):529-536. https://doi.org/10.1111/ajag.12829
Anand A, Harley C, Visvanathan A, Shah ASV, Cowell J, MacLullich A, Shenkin S, Mills NL. The relationship between preoperative frailty and outcomes following transcatheter aortic valve implantation: a systematic review and meta-analysis. European Heart Journal — Quality of Care and Clinical Outcomes. 2017;3(2):123-132. https://doi.org/10.1093/ehjqcco/qcw030
U.S. National Library of Medicine. ClinicalTrials.gov. Identifier: NCT 01845207. https://clinicaltrials.gov/ct2/show/NCT01845207
Lantelme P, Lacour T, Bisson A, Herbert J, Ivanes F, Bourguignon T, Quilliet L, Angoulvant D, Harbaoui B, Babuty D, Etienne CS, Deharo P, Bernard A, Fauchier L. Futility Risk Model for Predicting Outcome After Transcatheter Aortic Valve Implantation. American Journal of Cardiology. 2020;130:100-107. https://doi.org/10.1016/j.amjcard.2020.05.043
Nishimura RA, Otto CM, Bonow RO, Carabello BA, Erwin JP 3rd, Guyton RA, O’Gara PT, Ruiz CE, Skubas NJ, Sorajja P, Sundt TM 3rd, Thomas JD. American College of Cardiology/American Heart Association Task Force on Practice Guidelines. 2014 AHA/ACC guideline for the management of patients with valvular heart disease: executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. JACC: Journal of the American College of Cardiology. 2014;63(22):2438-2488. https://doi.org/10.1016/j.jacc.2014.02.537